Keywords
AnakinraCanakinumabMedicineImmunologyMonoclonal antibodyInflammationInterleukin 1 receptor antagonistReceptor antagonistCytokinePharmacologyReceptorAntibodyDiseaseAntagonistInternal medicine
Affiliated Institutions
Related Publications
Interleukin-6 Receptor Blockade Selectively Reduces IL-21 Production by CD4 T Cells and IgG4 Autoantibodies in Rheumatoid Arthritis
Interleukin-6 (IL-6) levels are known to be increased in patients with rheumatoid arthritis (RA). Tocilizumab, a monoclonal antibody to the IL-6 receptor (IL-6R), reduces diseas...
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
During active disease, patients with systemic-onset juvenile chronic arthritis (S-JCA) demonstrate a rise and fall in serum interleukin-6 (IL-6) that parallels the classic quoti...
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
SUMMARY Severe acute respiratory syndrome (SARS) is a recently emerged infectious disease caused by a novel coronavirus, but its immunopathological mechanisms have not yet been ...
Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.
We have characterized the progressive stages of chronic intestinal inflammation that develops spontaneously in specific pathogen-free (SPF) mice with a targeted disruption in th...
Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis
Hemophagocytic lymphohistocytosis (HLH) is characterized by fulminant cytokine storm leading to multiple organ dysfunction and high mortality. HLH is classified into familial (f...
Publication Info
- Year
- 2012
- Type
- review
- Volume
- 11
- Issue
- 8
- Pages
- 633-652
- Citations
- 1703
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
1703
OpenAlex
Cite This
Charles A. Dinarello,
Anna Simon,
Jos W.M. van der Meer
(2012).
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases.
Nature Reviews Drug Discovery
, 11
(8)
, 633-652.
https://doi.org/10.1038/nrd3800
Identifiers
- DOI
- 10.1038/nrd3800